SCI
Mina Girgis, MD
Resident/ PGY-2
Mount Sinai Hospital
New York, New York, United States
Jacob K. Meariman, MD, PhD
Resident Physician
Icahn School of Medicine at Mount Sinai
Brooklyn, New York, United States
Miguel X. Escalon, MD, MPH
Professor
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Mina Girgis, MD
Mount Sinai Hospital
New York, New York, United States
Progressive Myelopathy due to Spinal Dural AVF
72-year-old male with history of diabetes and lumbar herniated discs presenting for evaluation for 15-month history of progressive waxing and waning bilateral lower extremity weakness. Weakness was associated with falls and 20-pound wight loss. MRI thoracic spine with spinal cord signal change from T6 to conus with unclear etiology. Had serum NMO/MOG testing which was unremarkable. Repeat MRI thoracic spine showed progression of signal change from T6 to T2. EMG/NCS unremarkable. MRA thoracic spine demonstrated anterior cord enhancement with vascular abnormalities concerning for spinal dural AVF. Underwent spinal DSA and found to have left L3 dural AVF.
This case highlights the importance of considering spinal dural AVF in elderly patients presenting with progressive lower extremity weakness, especially when MRI demonstrates longitudinally extensive T2 hyperintensity and no clear demyelinating or compressive cause. Prompt diagnosis is crucial, as timely intervention (surgical or endovascular) can prevent irreversible spinal cord damage.